MEI PHARMA INC (MEIP) Stock Analyst Earnings Estimates
NASDAQ:MEIP - Nasdaq - US55279B3015 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40.7M 16.95% | 48.82M 19.95% | 65.297M 33.75% | -100.00% | 25.5M | 25.5M | 25.5M | 1.445B 5,566.67% | 3.007B 108.10% | |
| EBITDA YoY % growth | -75.15M -24.98% | -36.37M 51.60% | 25.824M 171.00% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -75.48M -24.93% | -36.76M 51.30% | 25.441M 169.21% | -41.956M -264.91% | -29.939M 28.64% | -33.288M -11.18% | -36.003M -8.16% | 19.38M 153.83% | 24.48M 26.32% | |
| Operating Margin | -185.45% | -75.30% | 38.96% | N/A | -117.41% | -130.54% | -141.19% | 1.34% | 0.81% | |
| EPS YoY % growth | -4.91 -991.11% | -4.63 5.70% | 2.67 157.67% | -6.41 -339.91% | -3.78 40.92% | -1.59 57.95% | -1.14 28.21% | 0.01 100.89% | 0.02 100.00% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -2.76 -82.78% | -1.46 | -1.30 | -88.56% |
| Q3 2024 Q2Q % growth | -1.37 40.95% | -1.55 | 0.18 | 11.64% |
| Q2 2024 Q2Q % growth | -1.66 -203.75% | -1.35 | -0.31 | -22.83% |
| Q1 2024 Q2Q % growth | 8.46 452.50% | -2.16 | 10.62 | 491.23% |
| Q4 2023 Q2Q % growth | -1.51 37.08% | -2.46 | 0.95 | 38.70% |
| Q3 2023 Q2Q % growth | -2.32 -65.71% | -2.92 | 0.60 | 20.66% |
| Q2 2023 Q2Q % growth | 1.60 260.00% | -3.06 | 4.66 | 152.29% |
| Q1 2023 Q2Q % growth | -2.40 -2,081.82% | -2.92 | 0.52 | 17.92% |
| Q4 2022 Q2Q % growth | -2.40 -4,700.00% | -3.79 | 1.39 | 36.65% |
| Q3 2022 Q2Q % growth | -1.40 -400.00% | -3.72 | 2.32 | 62.40% |
| Q2 2022 Q2Q % growth | -1.00 -900.00% | -4.13 | 3.13 | 75.79% |
| Q1 2022 Q2Q % growth | -0.11 -450.00% | -0.13 | 0.02 | 14.41% |
| Q4 2021 Q2Q % growth | -0.05 73.68% | -0.18 | 0.13 | 71.99% |
| Q3 2021 Q2Q % growth | -0.28 -600.00% | -0.17 | -0.11 | -68.93% |
| Q2 2021 Q2Q % growth | -0.10 61.54% | -0.14 | 0.04 | 26.21% |
| Q1 2021 Q2Q % growth | -0.02 50.00% | -0.08 | 0.06 | 76.09% |
| Q4 2020 Q2Q % growth | -0.19 -26.67% | 0.22 | -0.41 | -186.64% |
| Q3 2020 Q2Q % growth | -0.04 83.33% | -0.14 | 0.10 | 71.40% |
| Q2 2020 Q2Q % growth | -0.26 -73.33% | -0.17 | -0.09 | -51.43% |
| Q1 2020 Q2Q % growth | -0.04 80.95% | -0.17 | 0.13 | 76.93% |
| Q4 2019 Q2Q % growth | -0.15 | -0.20 | 0.05 | 25.85% |
| Q3 2019 Q2Q % growth | -0.24 | -0.17 | -0.07 | -39.58% |
| Q2 2019 Q2Q % growth | -0.15 | -0.12 | -0.03 | -22.55% |
| Q1 2019 Q2Q % growth | -0.21 | -0.12 | -0.09 | -71.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | 38.25K | -38.25K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2024 Q2Q % growth | 64.545M 639.35% | 64.545M | % | |
| Q4 2023 Q2Q % growth | 1.457M -87.23% | 949.62K | 507.38K | 53.43% |
| Q3 2023 Q2Q % growth | 5.894M -39.17% | 471.577K | 5.422M | 1,149.85% |
| Q2 2023 Q2Q % growth | 32.74M 176.75% | 5.399M | 27.341M | 506.41% |
| Q1 2023 Q2Q % growth | 8.73M 12.50% | 6.015M | 2.715M | 45.14% |
| Q4 2022 Q2Q % growth | 11.41M 53.15% | 4.865M | 6.545M | 134.53% |
| Q3 2022 Q2Q % growth | 9.69M 19.48% | 3.508M | 6.182M | 176.23% |
| Q2 2022 Q2Q % growth | 11.83M -6.11% | 3.328M | 8.502M | 255.47% |
| Q1 2022 Q2Q % growth | 7.76M 16.87% | 12.509M | -4.749M | -37.96% |
| Q4 2021 Q2Q % growth | 7.45M -69.40% | 3.643M | 3.807M | 104.50% |
| Q3 2021 Q2Q % growth | 8.11M 554.03% | 5.52M | 2.59M | 46.92% |
| Q2 2021 Q2Q % growth | 12.6M 1,147.52% | 3.909M | 8.691M | 222.33% |
| Q1 2021 Q2Q % growth | 6.64M 472.41% | 4.371M | 2.269M | 51.91% |
| Q4 2020 Q2Q % growth | 24.35M 2,054.87% | 45.976M | -21.626M | -47.04% |
| Q3 2020 Q2Q % growth | 1.24M -0.80% | 1.61M | -370K | -22.98% |
| Q2 2020 Q2Q % growth | 1.01M -50.73% | 1.603M | -593K | -36.99% |
| Q1 2020 Q2Q % growth | 1.16M 136.73% | 1.356M | -196K | -14.45% |
| Q4 2019 Q2Q % growth | 1.13M | 847.62K | 282.38K | 33.31% |
| Q3 2019 Q2Q % growth | 1.25M | 704.524K | 545.476K | 77.42% |
| Q2 2019 Q2Q % growth | 2.05M | 2.126M | -76K | -3.57% |
| Q1 2019 Q2Q % growth | 490K | 396.78K | 93.22K | 23.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -10.37% | -10.37% |
| Revenue | N/A | N/A | -100% | -100% |